Atossa Therapeutics outlines 2025 progress and 2026 plans for drug development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. NVDA
2. SPY
3. DKS
4. INTU
5. AAPL
6. XPEV
7. SPCX
8. USO
9. SMTC
10. VEEV

Go back to Atossa Therapeutics outlines 2025 progress and 2026 plans for drug development
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 2.68 +0.04 (1.52%)
Previous Close $2.64    52 Week High $3.64 
Open $2.62    52 Week Low $0.14 
Day High $2.69    P/E N/A 
Day Low $2.58    EPS $0.00 
Volume 49,692